ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?

ADMA Biologics (ADMA) and Grifols (GRFS) are leading producers of plasma-derived therapies, specializing in immunoglobulin treatments for immunodeficiencies and other conditions.ADMA Biologics markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases.Grifols is a leader in essential plasma-derived medicines and transfusion medicine. The company develops, produces, and provides innovative healthcare services and solutions in more than 110 coun ...